Theravance Inc (NASDAQ:THRX)

18.37
BATS BZX Real-Time Price
As of 10:30am ET
 +0.31 / +1.72%
Today’s Change
10.58
Today|||52-Week Range
31.80
+29.82%
Year-to-Date

Today’s Trading

Previous close18.06
Today’s open18.46
Day’s range18.05 - 18.62
Volume195,458
Average volume (3 months)986,992
Market cap$2.1B
Dividend yield5.43%
Data as of 10:17am ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+91.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-1.45-2.41%
ASPXAuspex Pharmaceutica...-0.22-0.33%
IRWDIronwood Pharmaceuti...+0.54+3.50%
LCILannett Company Inc-0.96-1.54%
Data as of 10:30am ET, 03/02/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account